Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activation of complement in IgA nephropathy.

R J Wyatt1, B A Julian

  • 1Department of Pediatrics, University of Tennessee, Memphis.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Familial IgA nephropathy in southeastern Kentucky.

Clinical nephrology·2010
Same author

Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Kidney & blood pressure research·2008
Same journal

Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

High Protein Diets: What to Tell Our Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Progressive Kidney Dysfunction and Ocular Clues: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Influence of Lactate Dehydrogenase on the Measurement of Blood Bicarbonate.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Urinary CXCL9 and CXCL10, Interstitial Inflammation and Disease Activity Over Time in Acute Interstitial Nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

The complement system plays a role in IgA nephropathy (IgAN) pathogenesis. Elevated plasma iC3b-C3d neoantigen levels correlate with kidney damage severity in IgAN patients.

Area of Science:

  • Immunology
  • Nephrology
  • Complement System Biology

Background:

  • The complement system, particularly the alternative and terminal pathways, is implicated in IgA nephropathy (IgAN) pathogenesis.
  • Mesangial deposits in IgAN typically show alternative pathway components (C3, properdin) and the membrane attack complex (C5b-9), but lack classical pathway components (C1q, C4).
  • Plasma analysis often reveals complement activation fragments (iC3b, C3d, iC3b-C3d neoantigen) despite normal serum complement levels.

Purpose of the Study:

  • To investigate the correlation between complement activation fragments in plasma and the severity of kidney damage in IgA nephropathy.
  • To explore the diagnostic utility of plasma iC3b-C3d neoantigen as a biomarker for IgAN histologic changes.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to quantify plasma concentrations of iC3b-C3d neoantigen.

Related Experiment Videos

  • Immunofluorescence staining was performed on renal biopsy specimens to assess complement component deposition.
  • Histologic changes in renal biopsies were evaluated and correlated with plasma neoantigen levels.

    • Main Results:

    • Plasma concentrations of iC3b-C3d neoantigen were detected in IgAN patients.
    • A significant correlation was observed between plasma iC3b-C3d neoantigen levels and the severity of histologic changes in renal biopsy specimens.
    • No other clinical features of IgAN correlated with plasma iC3b-C3d neoantigen concentrations.

    Conclusions:

    • Plasma iC3b-C3d neoantigen is a potential biomarker for assessing renal histologic severity in IgA nephropathy.
    • Complement activation, specifically of the alternative and terminal pathways, is a key feature in IgAN pathogenesis.
    • Further research is warranted to elucidate the precise role of complement fragments in IgAN progression and clinical outcomes.